CUREVAC NV (5CV.DE) Stock Income Statement
FRA:5CV - Deutsche Boerse Ag - NL0015436031 - Common Stock - Currency: EUR
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 535.18M | 53.76M | 67.40M | 103.00M | 48.90M | |||
| Cost Of Goods | 105.83M | 116.28M | 159.00M | 238.20M | 14.20M | |||
| Gross Profit | 429.35M | -62.52M | -91.60M | -135.20M | 34.70M | |||
| Operating Expenses | 251.67M | 207.16M | 133.40M | 343.50M | 144.50M | |||
| Research and Development | 141.44M | 107.19M | 53.90M | 811.60M | 111.20M | |||
| Selling, General, and Administrative Expenses | 66.32M | 81.79M | 95.30M | 93.20M | 48.20M | |||
| Operating Income | 177.68M | -269.69M | -225.00M | -478.70M | -109.80M | |||
| Interest Income/Expense | 13.20M | 14.24M | 300.00K | -200.00K | -20.00M | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | -24.15M | |||
| Non Recurring Items | 0.00 | -4.52M | -24.50M | 66.40M | N/A | |||
| Income Before Taxes | 190.88M | -259.97M | -249.20M | -412.50M | -129.80M | |||
| Income Tax | 28.70M | 198.00K | -100.00K | -800.00K | -700.00K | |||
| Net Income | 162.19M | -260.17M | -249.00M | -411.70M | -129.10M | |||
| EBITDA | 196.49M | -246.30M | -201.30M | -463.00M | -99.10M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 0.72 | -1.18 | -1.28 | -2.20 | -0.72 | |||
| Non GAAP EPS | 0.73 | -1.18 | -1.24 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 80.23% | -116.30% | -135.91% | -131.26% | 70.96% | |||
| Profit Margin | 30.30% | -483.96% | -369.44% | -399.71% | -264.01% | |||
| Operating Profit Margin | 33.20% | -501.67% | -333.83% | -464.76% | -224.54% | |||
All data in EUR